White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria

Molecular Genetics and Metabolism

Volumn 110, Issue 3, 2013, Pages 213-217

  White, Desirée A ^a   Antenor Dorsey, Jo Ann V ^b   Grange, Dorothy K ^b   Hershey, Tamara ^b,c   Rutlin, Jerrel ^b   Shimony, Joshua S ^c   McKinstry, Robert C ^b,c   Christ, Shawn E ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Diffusion tensor imaging; Executive; Phenylketonuria; Sapropterin; Tetrahydrobiopterin; White matter

Indexed keywords

PHENYLALANINE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; MALE; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER; WORKING MEMORY;

DIFFUSION TENSOR IMAGING; EXECUTIVE; PHENYLKETONURIA; SAPROPTERIN; TETRAHYDROBIOPTERIN; WHITE MATTER;

ADOLESCENT; ADULT; BIOPTERIN; BRAIN; CASE-CONTROL STUDIES; CHILD; DIFFUSION TENSOR IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PHENYLALANINE; PHENYLKETONURIAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885431162     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.07.010     Document Type: Article

References (19)

1. de Groot M.J., Hoeksma M., Blau N., Reijngoud D.J., van Spronsen F.J. Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol. Genet. Metab. 2010, 99(Suppl. 1):S86-S89.
2. Paine R.S., Hsia D.Y. The dietary phenylalanine requirements and tolerances of phenylketonuric patients. AMA J. Dis. Child. 1957, 94:224-230.
3. Moyle J.J., Fox A.M., Bynevelt M., Arthur M., Burnett J.R. A neuropsychological profile of off-diet adults with phenylketonuria. J. Clin. Exp. Neuropsychol. 2007, 29:436-441.
4. Antenor-Dorsey J.V., Hershey T., Ruttlin J., Shimony J.S., McKinstry R.C., Grange D.K., Christ S.E., White D.A. White matter integrity and executive abilities in individuals with phenylketonuria. Mol. Genet. Metab. 2013, 10.1016/j.ymgme.2013.03.020.
5. Anderson P.J., Leuzzi V. White matter pathology in phenylketonuria. Mol. Genet. Metab. 2010, 99(Suppl. 1):S3-S9.
6. Brumm V.L., Grant M.L. The role of intelligence in phenylketonuria: a review of research and management. Mol. Genet. Metab. 2010, 99(Suppl. 1):S18-S21.
7. Christ S.E., Huijbregts S.C., De Sonneville L.M., White D.A. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol. Genet. Metab. 2010, 99(Suppl. 1):S22-S32.
8. DeRoche K., Welsh M. Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev. Neuropsychol. 2008, 33:474-504.
9. van Spronsen F.J., Enns G.M. Future treatment strategies in phenylketonuria. Mol. Genet. Metab. 2010, 99(Suppl. 1):S90-S95.
10. Gassio R., Vilaseca M.A., Lambrushini N., Boix C., Fusté M.E., Campistol J. Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterin. Mol. Genet. Metab. 2010, 99(Suppl. 1):S75-S78.
11. Mukherjee P., Miller J.H., Shimony J.S., Conturo T.E., Lee B.C.P., Almli C.R., McKinstry R.C. Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology 2001, 221:349-358.
12. Dezortova M., Hajek M., Tintera J., Hejcmanova L., Sykova E. MR in phenylketonuria-related brain lesions. Acta Radiol. 2001, 42:459-466.
13. Kono K., Okano Y., Nakayama K., Hase Y., Minamikawa S., Ozawa N., Yokote H., Inoue Y. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 2005, 236:630-636.
14. Leuzzi V., Tosetti M., Montanaro D., Carducci C., Artiola C., Carducci C., Antonozzi I., Burroni M., Carnevale F., Chiarotti F., Popolizio T., Giannatempo G.M., D'Alesio V., Scarabino T. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0Tesla MRI and magnetic resonance spectroscopy (1H MRS) study. J. Inherit. Metab. Dis. 2007, 30:209-216.
15. Scarabino T., Popolizio T., Tosetti M., Montanaro D., Giannatempo G.M., Terlizzi R., Pollice S., Maiorana A., Maggialetti N., Carriero A., Leuzzi V., Salvolini U. Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol. Med. 2009, 114:461-474.
16. Vermathen P., Robert-Tissot L., Pietz J., Lutz T., Boesch C., Kreis R. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn. Reson. Med. 2007, 58:1145-1156.
17. White D.A., Connor L.T., Nardos B., Shimony J.S., Archer R., Snyder A.Z., Moinuddin A., Grange D.K., Steiner R.D., McKinstry R.C. Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosum. Mol. Genet. Metab. 2010, 99(Suppl. 1):S41-S46.
18. Peng H., Peck D., White D.A., Christ S.E. Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria. J. Inherit. Metab. Dis. 2013, (in press).
19. Cleary M.A., Walter J.H., Wraith J.E., White F., Tyler K., Jenkins J.P. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J. Pediatr. 1995, 127:251-255.